Section Arrow
BVS.NASDAQ
- Bioventus
Quotes are at least 15-min delayed:2026/03/29 00:29 EDT
Regular Hours
Last
 8.94
-0.32 (-3.46%)
Day High 
9.39 
Prev. Close
9.26 
1-M High
9.53 
Volume 
712.93K 
Bid
8.85
Ask
9.58
Day Low
8.82 
Open
9.24 
1-M Low
8.11 
Market Cap 
620.20M 
Currency 美元 
P/E 27.52 
%Yield -- 
10-SMA 8.96 
20-SMA 8.84 
50-SMA 8.46 
52-W High 9.56 
52-W Low 5.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.33/0.86
Enterprise Value
899.15M
Balance Sheet
Book Value Per Share
2.73
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
573.28M
Operating Revenue Per Share
7.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.17-1-1.43%36.18PE
ABTAbbott Laboratories103.99-0.58-0.55%28.17PE
MDTMedtronic plc87.14+0.18+0.21%24.57PE
PACBPacific Biosciences of California1.26-0.09-6.67%-- 
VNRXVolitionRX Limited0.1966+0.0036+1.87%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.